Neuberger High Yield Strategies Fund Announces Increase in Leverage
Neuberger High Yield Strategies Fund (NHS) plans to increase its revolving debt financing by $25 million and issue $10 million in additional Series D Preferred Shares, subject to documentation and closing conditions. The fund expects to finalize these changes within a week, increasing its total committed debt to $135 million and outstanding Series D Preferred Shares to $50 million. This move aims to align leverage with the fund's current asset level following its recent rights offering.
How this was made
The 30-second read
Why it matters
The additional $35M of financing expands the fund's borrowing capacity, potentially allowing larger asset purchases.
Market read
Primary disclosure of a modest capital raise for a niche high‑yield fund.
What to watch
Potential impact of upcoming interest‑rate environment on fund's cost of debt.
Background
Neuberger High Yield Strategies Fund is a closed‑end fund focused on high‑yield assets.
Ticker impact
Fund announced a $25M increase in revolving loan facility and $10M Series D preferred issuance.
Modest upside if market views leverage positively, downside risk if debt concerns rise.
New capital raise is primary disclosure but modest in scale; impact limited to fund's share price.
Market effects
May signal increased activity in high‑yield fund space.
Limited to U.S. listed closed‑end fund market.
Minimal global impact.
Counterpoint
Higher leverage could strain fund if credit conditions tighten.
Key entities
- FundNeuberger High Yield Strategies Fund Inc.
Issuer of the announced leverage increase.
